A detailed history of State Of Wisconsin Investment Board transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, State Of Wisconsin Investment Board holds 34,407 shares of PLRX stock, worth $423,894. This represents 0.0% of its overall portfolio holdings.

Number of Shares
34,407
Previous 54,332 36.67%
Holding current value
$423,894
Previous $584,000 34.08%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.52 - $14.35 $209,611 - $285,923
-19,925 Reduced 36.67%
34,407 $385,000
Q2 2024

Aug 14, 2024

BUY
$10.58 - $15.61 $290,643 - $428,822
27,471 Added 102.27%
54,332 $584,000
Q1 2024

May 14, 2024

SELL
$14.14 - $19.59 $49,687 - $68,839
-3,514 Reduced 11.57%
26,861 $400,000
Q4 2023

Feb 12, 2024

SELL
$12.85 - $19.15 $11,847 - $17,656
-922 Reduced 2.95%
30,375 $550,000
Q3 2023

Nov 14, 2023

SELL
$14.58 - $20.15 $106,958 - $147,820
-7,336 Reduced 18.99%
31,297 $542,000
Q2 2023

Aug 14, 2023

BUY
$18.12 - $30.56 $88,751 - $149,682
4,898 Added 14.52%
38,633 $700,000
Q1 2023

May 15, 2023

SELL
$18.73 - $36.26 $54,672 - $105,842
-2,919 Reduced 7.96%
33,735 $897,000
Q4 2022

Feb 14, 2023

BUY
$17.0 - $25.43 $623,118 - $932,111
36,654 New
36,654 $708,000
Q2 2022

Aug 15, 2022

BUY
$4.11 - $8.75 $140,973 - $300,125
34,300 Added 78.13%
78,200 $626,000
Q1 2022

May 13, 2022

BUY
$7.01 - $14.1 $204,692 - $411,720
29,200 Added 198.64%
43,900 $308,000
Q4 2020

Feb 03, 2021

BUY
$19.89 - $32.99 $292,383 - $484,953
14,700 New
14,700 $334,000

Others Institutions Holding PLRX

About PLIANT THERAPEUTICS, INC.


  • Ticker PLRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,682,000
  • Market Cap $600M
  • Description
  • Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...
More about PLRX
Track This Portfolio

Track State Of Wisconsin Investment Board Portfolio

Follow State Of Wisconsin Investment Board and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.